Ronald G. Gelbman, Director at HAEMONETICS CORP (HAE), sold 11,366 shares at $40.30 ($458K) on 2016-12-12, disclosed to the SEC on 2016-12-14.
Open-market sale of $458k HAE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.30 | 5,683 | $229K | 50.0% |
| 2 | $40.30 | 5,683 | $229K | 50.0% |
| Total | $40.30 avg | 11,366 | $458K | 100% |
| Filing → |
| HAE | SELL | 2019-02-19 | $1.4M | — | Filing → |
| HAE | SELL | 2018-12-18 | $892K | — | Filing → |
| HAE | SELL | 2017-11-17 | $331K | — | Filing → |